Protective effects of a novel 5-HT3 receptor antagonist, N-n-butyl-3-methoxy quinoxaline-2-carboxamide (6o) against chronic unpredictable mild stress-induced behavioral changes and biochemical alterations

Pharmacology Biochemistry and Behavior

Volumn 122, Issue , 2014, Pages 234-239

  Bhatt, Shvetank ^a   Mahesh, Radhakrishnan ^a   Jindal, Ankur ^a   Devadoss, Thangaraj ^a  

^a BIRLA INSTITUTE OF TECHNOLOGY AND SCIENCE   (India)

Author keywords

"Compound 6o"; Forced swim test; Glutathione; Nitrite; SOD

Indexed keywords

ANTIOXIDANT; BRAIN ENZYME; CATALASE; FLUOXETINE; GLUTATHIONE; LIPID PEROXIDE; N N BUTYL 3 METHOXY QUINOXALINE 2 CARBOXAMIDE; NEUROPROTECTIVE AGENT; NITRITE; QUINOXALINE DERIVATIVE; SEROTONIN 3 ANTAGONIST; SUCROSE; SUPEROXIDE DISMUTASE; UNCLASSIFIED DRUG; ANTIDEPRESSANT AGENT; ANXIOLYTIC AGENT; N-N-BUTYL-3-METHOXYQUINOXALINE-2-CARBOXAMIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIOXIDANT ACTIVITY; ARTICLE; BEHAVIOR CHANGE; BRAIN TISSUE; CHRONIC DRUG ADMINISTRATION; CHRONIC STRESS; CONTROLLED STUDY; DEPRESSION; EXPERIMENTAL DISEASE; FORCED SWIM TEST; IMMOBILITY; LOCOMOTION; LONG TERM CARE; MALE; MOUSE; NEUROPROTECTION; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROPHYLAXIS; SUCROSE PREFERENCE TEST; ANIMAL; CHRONIC DISEASE; DRUG EFFECTS; MENTAL STRESS; METABOLISM; PHYSIOLOGY; PREVENTION AND CONTROL;

ANIMALS; ANTI-ANXIETY AGENTS; ANTIDEPRESSIVE AGENTS; ANTIOXIDANTS; CHRONIC DISEASE; DEPRESSION; MALE; MICE; OXIDATIVE STRESS; QUINOXALINES; SEROTONIN 5-HT3 RECEPTOR ANTAGONISTS; STRESS, PSYCHOLOGICAL;

EID: 84899828575     PISSN: 00913057     EISSN: 18735177     Source Type: Journal    
DOI: 10.1016/j.pbb.2014.03.029     Document Type: Article

References (52)

1. H. Anisman Cascading effects of stressors and inflammatory immune system activation: implications for major depressive disorder J Psychiatry Neurosci 34 2009 4 20
2. S. Bekris, K. Antoniou, S. Daskas, and Z. Papadopoulou-Daifoti Behavioural and neurochemical effects induced by chronic mild stress applied to two different rat strains Behav Brain Res 161 2005 45 59
3. S. Bhatt, R. Mahesh, A. Jindal, and T. Devadoss Anti-depressant like activity of N-n-butyl-3-methoxyquinoxaline-2-carboxamide (6o) a 5-HT3 receptor antagonist Indian J Exp Biol 51 2013 435 443
4. M. Bilici, H. Efe, M.A. Koroglu, H.A. Uydu, M. Bekaroglu, and O. Deger Antioxidative enzyme activities and lipid peroxidation in major depression: alterations by antidepressant treatments J Affect Disord 64 2001 43 51
5. J.R. Boissier, and P. Simon Action of caffeine on the spontaneous motility of the mouse Arch Int Pharmacodyn Ther 158 1965 212 221
6. C.O. Bondi, G. Rodriguez, G.G. Gould, A. Frazer, and D.A. Morilak Chronic unpredictable stress induces a cognitive deficit and anxiety-like behavior in rats that is prevented by chronic antidepressant drug treatment Neuropsychopharmacology 33 2008 320 331
7. J.J. Bonfiglio, C. Inda, D. Refojo, F. Holsboer, E. Arzt, and S. Silberstein The corticotropin-releasing hormone network and the hypothalamic-pituitary-adrenal axis: molecular and cellular mechanisms involved Neuroendocrinology 94 2011 12 20
8. M. Bourin, J.P. Redrobe, and G.B. Baker Pindolol does not act only on 5-HT1A receptors in augmenting antidepressant activity in the mouse forced swimming test Psychopharmacology 136 1998 226 234
9. P.C. Casarotto, and R. Andreatini Repeated paroxetine treatment reverses anhedonia induced in rats by chronic mild stress or dexamethasone Eur Neuropsychopharmacol 17 2007 735 742
10. C. Ducottet, G. Griebel, and C. Belzung Effects of the selective nonpeptide corticotropin releasing factor receptor 1 antagonist antalarmin in the chronic mild stress model of depression in mice Prog Neuropsychopharmacol Biol Psychiatry 27 2003 625 631
11. G.L. Ellman Tissue sulfidryl groups Arch Biochem Biophys 82 1959 70 77
12. I. Eren, M. Naziroglu, A. Demirdas, O. Celik, A.C. Uguz, and A. Altunbasak et al. Venlafaxine modulates depression-induced oxidative stress in brain and medulla of rat Neurochem Res 32 2007 497 505
13. P. Fan Inhibition of a 5-HT3 receptor-mediated current by the selective serotonin uptake inhibitor, fluoxetine Neurosci Lett 173 1994 210 212
14. P. Fan Effects of antidepressants on the inward current mediated by 5-HT3 receptors in rat nodose ganglion neurons Brit J Pharmacol 112 1994 741 744
15. L.C. Green, D.A. Wagner, J. Glogowski, P.L. Skipper, J.S. Wishnok, and S.R. Tannenbaum Analysis of nitrate, nitrite, and [15N]nitrate in biological fluids Anal Biochem 126 1982 131 138
16. J. Gronli, R. Murison, E. Fiske, B. Bjorvatn, E. Sorensen, C.M. Portas, and R. Ursin Effects of chronic mild stress on sexual behavior, locomotor activity and consumption of sucrose and saccharine solutions Physiol Behav 84 2005 571 577
17. F. Holsboer The corticosteroid receptor hypothesis of depression Neuropsychopharmacology 23 2000 477 501
18. A. Jindal, R. Mahesh, and S. Bhatt Etazolate, a phosphodiesterase 4 inhibitor reverses chronic unpredictable mild stress-induced depression-like behavior and brain oxidative damage Pharmacol Biochem Behav 105 2013 63 70
19. A.V. Kalueff, P.S. Gallagher, and D.L. Murphy Are serotonin transporter knockout mice 'depressed'?: hypoactivity but no anhedonia Neuroreport 17 2006 1347 1351
20. R.J. Katz, and K. Schmaltz Dopaminergic involvement in attention. A novel animal model Prog Neuropsychopharmacol Biol Psychiatry 4 1980 585 590
21. R.J. Katz, K.A. Roth, and B.J. Carroll Acute and chronic stress effects on open field activity in the rat: implications for a model of depression Neurosci Biobehav Rev 5 1981 247 251
22. S.D. Khanzode, G.N. Dakhale, S.S. Khanzode, A. Saoji, and R. Palasodkar Oxidative damage and major depression: the potential antioxidant action of selective serotonin reuptake inhibitors Redox Rep 8 2003 365 370
23. G.J. Kilpatrick, A. Butler, J. Burridge, and A.W. Oxford 1-(m-chlorophenyl)-biguanide, a potent high affinity 5-HT3 receptor agonist Eur J Pharmacol 182 1990 193 197
24. J. Kodydková, L. Vávrová, M. Zeman, R. Jirák, J. Macásek, and B. Stanková et al. Antioxidative enzymes and increased oxidative stress in depressive women Clin Biochem 42 2009 1368 1374
25. B. Kumar, A. Kuhad, and A. Chopra Neuropsychopharmacological effect of sesamol in unpredictable chronic mild stress model of depression: behavioral and biochemical evidences Psychopharmacology 214 2011 819 828
26. B. Kumari, A. Kumar, and A. Dhir Protective effect of non-selective and selective COX-2-inhibitors in acute immobilization stress induced behavioral and biochemical alterations Pharmacol Rep 59 2007 699 707
27. M.H. Larsen, J.D. Mikkelsen, A. Hay-Schmidt, and C. Sandi Regulation of brain-derived neurotrophic factor (BDNF) in the chronic unpredictable stress rat model and the effects of chronic antidepressant treatment J Psychiatr Res 44 2010 808 816
28. J. Liu, X. Wang, M.K. Shigenaga, H.C. Yeo, A. Mori, and B.N. Ames Immobilization stress causes oxidative damage to lipid, protein, and DNA in the brain of rats FASEB J 10 1996 1532 1538
29. X.Y. Lu, C.S. Kim, A. Frazer, and W. Zhang Leptin: a potential novel antidepressant Proc Natl Acad Sci 103 2006 1593 1598
30. G. Lucca, C.M. Comim, S.S. Valvassori, G.Z. Reus, F. Vuolo, and F. Petronilho et al. Effects of chronic mild stress on the oxidative parameters in the rat brain Neurochem Int 54 2009 358 362
31. D.D. Luo, S.C. An, and X. Zhang Involvement of hippocampal serotonin and neuropeptide Y in depression induced by chronic unpredicted mild stress Brain Res Bull 77 2008 8 12
32. M. Maes, N. De Vos, R. Pioli, P. Demedts, A. Wauters, and H. Neels et al. Lower serum vitamin E concentrations in major depression. Another marker of lowered antioxidant defenses in that illness J Affect Disord 58 2000 241 246
33. M. Maes, P. Galecki, Y.S. Chang, and M. Berk A review on the oxidative and nitrosative stress (O&NS) pathways in major depression and their possible contribution to the (neuro) degenerative processes in that illness Prog Neuropsychopharmacol Biol Psychiatry 35 2011 676 692
34. R. Mahesh, S. Bhatt, T. Devadoss, A.K. Jindal, B.K. Gautam, and D.K. Pandey Antidepressant potential of 5-HT3 receptor antagonist, N-n-propyl-3-ethoxyquinoxaline-2-carboxamide (6n) J Young Pharm 4 2012 235 244
35. T.M. Michel, S. Frangou, D. Thiemeyer, S. Camara, J. Jecel, K. Nara, and A. Brunklaus et al. Evidence for oxidative stress in the frontal cortex in patients with recurrent depressive disorder - a postmortem study Psychiatry Res 151 2007 145 150
36. H.P. Misra, and I. Fridovich The role of superoxide anion in the autoxidation of epinephrine and a simple assay for superoxide dismutase J Biol Chem 247 1972 3170 3175
37. F. Ng, M. Berk, O. Dean, and A.I. Bush Oxidative stress in psychiatric disorders: evidence base and therapeutic implications Int J Neuropsychopharmacol 11 2008 851 876
38. G. Nowak, B. Szewczyk, J.M. Wieronska, P. Branski, A. Palucha, and A. Pilc et al. Antidepressant like effects of acute and chronic treatment with zinc in forced swim test and olfactory bulbectomy model in rats Brain Res Bull 61 2003 159 164
39. R.D. Porsolt, A. Bertin, and M. Jalfre Behavioral despair in mice. A primary screening test for antidepressants Arch Int Pharmacody 229 1977 327 336
40. R. Rajkumar, and R. Mahesh The auspicious role of the 5-HT3 receptor indepression: a probable neuronal target J Psychopharmacol 24 2010 455 469
41. A.K. Sinha Colorimetric assay of catalase Anal Biochem 47 1972 389 394
42. T. Strekalova, N. Gorenkova, E. Schunk, O. Dolgov, and D. Bartsch Selective effects of citalopram in a mouse model of stressinduced anhedonia with a control for chronic stress Behav Pharmacol 17 2006 271 287
43. S. Sugita, K.Z. Shen, and R.A. North 5-hydroxytryptamine is a fast excitatory transmitter at 5-HT3 receptors in rat amygdala Neuron 8 1992 199 203
44. E. Suzuki, G. Yagi, T. Nakaki, S. Kanba, and M. Asai Elevated plasma nitrate levels in depressive states J Affect Disord 63 2001 221 224
45. P. Willner (1991) Animal models as simulations of depression Trends Pharmacol Sci 12 1991 131 136
46. P. Willner Validity, reliability and utility of the chronic mild stress model of depression, a 10-year review and evaluation Psychopharmacology (Berl) 134 1997 319 329
47. P. Willner Chronic mild stress (CMS) revisited: consistency and behavioral-neurobiological concordance in the effects of CMS Neuropsychobiology 52 2005 90 110
48. P. Willner, R. Muscat, and M. Papp Chronic mild stress-induced anhedonia: a realistic animal model of depression Neurosci Biobehav Rev 16 1992 525 534
49. E.D. Wills (1966) Mechanism of lipid peroxide formation in animal Biochem J 99 1966 667 676
50. A. Zafir, A. Ara, and N. Banu In vivo antioxidant status: a putative target for antidepressant action Prog Neuropsychopharmacol Biol Psychiatry 33 2009 220 228
51. D. Zhang, X.S. Wen, X.Y. Wang, M. Shi, and Y. Zhao Antidepressant effect of Shudihuang on mice exposed to unpredictable chronic mild stress J Ethnopharmacol 123 2009 55 60
52. Q.G. Zhou, Y. Hu, Y. Hua, M. Hu, C.X. Luo, and X. Han et al. (2007) Neuronal nitric oxide synthase contributes to chronic stress-induced depression by suppressing hippocampal neurogenesis J Neurochem 103 2007 1843 1854